Publish time: 2021-11-12 00:00:00
12A-1080612
TW I811688、JP 7488914、PCT
To improve drug delivery to the target site, we have previously developed a proteoliposome-based system, using platelet membrane to improve the drug delivery via monocytes. However, preparation of platelet membrane is time consuming and with batch variation. In this study, we designed an aptamer sequence that specifically target to the monocytes. With the properties that aptamers are stable and easily prepared, we believe that this novel drug-delivery technology will be a new field for treating disease such as cancers. This technique leverages the paradigm of monocyte-infiltration into tumor during cancer progression.
- High stability
- Easy to fabricate
- Easy to modify
- Easy to store and control quality
- High affinity and selectivity to monocytes
- Drug delivery is enhanced by active monocyte-infiltration in pancreatic cancer apart from solely Enhanced and Permeability Retention Effect (EPR effect).
- To image pancreatic cancer and its liver and lung metastasis
- To treat solid and its metastatic tumor, including
1. Pancreatic cancer
2. Pancreatic cancer with liver and/or lung metastasis
Dr. Hsieh, Patrick Ching-Ho,
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Monocyte-Specific Aptamers and Uses Thereof for Enhancing Drug Delivery to Cancer